{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:11:10Z","timestamp":1785208270758,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,4]]},"DOI":"10.7759\/cureus.89383","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T05:32:12Z","timestamp":1754371932000},"source":"Crossref","is-referenced-by-count":1,"title":["Tuberculous Meningitis in a One-Year-Old Child With Isoniazid-Induced Hepatotoxicity: A Case Report"],"prefix":"10.7759","author":[{"given":"Satoshi","family":"Okada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Akutsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Global tuberculosis report. (2023). Accessed. October 20, 2024: https:\/\/iris.who.int\/bitstream\/handle\/10665\/373828\/9789240083851-eng.pdf?sequence=1."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S365753","article-title":"Tuberculous meningitis in children: treatment outcomes at discharge and its associated factors in Eastern Ethiopia: a five years retrospective study","volume":"15","author":"Abdella A","year":"2022","unstructured":"Abdella A, Deginet E, Weldegebreal F, Ketema I, Eshetu B, Desalew A. Tuberculous meningitis in children: treatment outcomes at discharge and its associated factors in Eastern Ethiopia: a five years retrospective study. Infect Drug Resist. 2022, 15:2743-51. 10.2147\/IDR.S365753","journal-title":"Infect Drug Resist"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/798764","article-title":"Tuberculous meningitis: diagnosis and treatment overview","volume":"2011","author":"Marx GE","year":"2011","unstructured":"Marx GE, Chan ED. Tuberculous meningitis: diagnosis and treatment overview. Tuberc Res Treat. 2011, 2011:798764. 10.1155\/2011\/798764","journal-title":"Tuberc Res Treat"},{"key":"ref4","unstructured":"Ministry of Health, Labour and Welfare. Tuberculosis Registrar Information Survey Annual Report tabulation results in 2023. (2023). Accessed: October 20, 2024: https:\/\/www.mhlw.go.jp\/content\/10900000\/001295037.pdf."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4081\/pr.2011.e16","article-title":"Antituberculosis drug-induced hepatotoxicity in children","volume":"3","author":"Donald PR","year":"2011","unstructured":"Donald PR. Antituberculosis drug-induced hepatotoxicity in children. Pediatr Rep. 2011, 3:e16. 10.4081\/pr.2011.e16","journal-title":"Pediatr Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002831","article-title":"Increasing tuberculosis rates and association with migration in children living in Campania region, Southern Italy: a 10-year cohort study","volume":"39","author":"Lo Vecchio A","year":"2020","unstructured":"Lo Vecchio A, Smarrazzo A, Amato C, et al.. Increasing tuberculosis rates and association with migration in children living in Campania region, Southern Italy: a 10-year cohort study. Pediatr Infect Dis J. 2020, 39:1017-22. 10.1097\/INF.0000000000002831","journal-title":"Pediatr Infect Dis J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2007.06.001","article-title":"Contrast medium-enhanced MRI findings and changes over time in stage I tuberculous meningitis","volume":"62","author":"Oztoprak I","year":"2007","unstructured":"Oztoprak I, G\u00fcm\u00fcs C, Oztoprak B, Engin A. Contrast medium-enhanced MRI findings and changes over time in stage I tuberculous meningitis. Clin Radiol. 2007, 62:1206-15. 10.1016\/j.crad.2007.06.001","journal-title":"Clin Radiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002192","article-title":"Antituberculosis drug-induced liver injury in children: incidence and risk factors during the two-month intensive phase of therapy","volume":"38","author":"Gafar F","year":"2019","unstructured":"Gafar F, Arifin H, Jurnalis YD, Yani FF, Fitria N, Alffenaar JC, Wilffert B. Antituberculosis drug-induced liver injury in children: incidence and risk factors during the two-month intensive phase of therapy. Pediatr Infect Dis J. 2019, 38:50-3. 10.1097\/INF.0000000000002192","journal-title":"Pediatr Infect Dis J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2009.06.011","article-title":"British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children","volume":"59","author":"Thwaites G","year":"2009","unstructured":"Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009, 59:167-87. 10.1016\/j.jinf.2009.06.011","journal-title":"J Infect"},{"key":"ref10","article-title":"Clinical and Research Information on Drug-Induced Liver Injury","author":"LiverTox","year":"2012","unstructured":"LiverTox. Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2012."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1441147","article-title":"Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement","volume":"15","author":"Sankar J","year":"2024","unstructured":"Sankar J, Chauhan A, Singh R, Mahajan D. Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement. Front Pharmacol. 2024, 15:1441147. 10.3389\/fphar.2024.1441147","journal-title":"Front Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001114","article-title":"Linezolid is associated with improved early outcomes of childhood tuberculous meningitis","volume":"35","author":"Li H","year":"2016","unstructured":"Li H, Lu J, Liu J, Zhao Y, Ni X, Zhao S. Linezolid is associated with improved early outcomes of childhood tuberculous meningitis. Pediatr Infect Dis J. 2016, 35:607-10. 10.1097\/INF.0000000000001114","journal-title":"Pediatr Infect Dis J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.06.009","article-title":"Fluoroquinolones in the management of tuberculous meningitis: systematic review and meta-analysis","volume":"77","author":"Rizvi I","year":"2018","unstructured":"Rizvi I, Malhotra HS, Garg RK, Kumar N, Uniyal R, Pandey S. Fluoroquinolones in the management of tuberculous meningitis: systematic review and meta-analysis. J Infect. 2018, 77:261-75. 10.1016\/j.jinf.2018.06.009","journal-title":"J Infect"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507062","article-title":"Intensified antituberculosis therapy in adults with tuberculous meningitis","volume":"374","author":"Heemskerk AD","year":"2016","unstructured":"Heemskerk AD, Bang ND, Mai NT, et al.. Intensified antituberculosis therapy in adults with tuberculous meningitis. N Engl J Med. 2016, 374:124-34. 10.1056\/NEJMoa1507062","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318269cc6a","article-title":"Treatment of tuberculosis with levofloxacin or moxifloxacin: report of 6 pediatric cases","volume":"31","author":"Chauny JV","year":"2012","unstructured":"Chauny JV, Lorrot M, Prot-Labarthe S, De Lauzanne A, Doit C, G\u00e9r\u00e9ral T, Bourdon O. Treatment of tuberculosis with levofloxacin or moxifloxacin: report of 6 pediatric cases. Pediatr Infect Dis J. 2012, 31:1309-11. 10.1097\/INF.0b013e318269cc6a","journal-title":"Pediatr Infect Dis J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3180cbd382","article-title":"Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders","volume":"26","author":"Noel GJ","year":"2007","unstructured":"Noel GJ, Bradley JS, Kauffman RE, et al.. Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders. Pediatr Infect Dis J. 2007, 26:879-91. 10.1097\/INF.0b013e3180cbd382","journal-title":"Pediatr Infect Dis J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/383892-tuberculous-meningitis-in-a-one-year-old-child-with-isoniazid-induced-hepatotoxicity-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T05:32:16Z","timestamp":1754371936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/383892-tuberculous-meningitis-in-a-one-year-old-child-with-isoniazid-induced-hepatotoxicity-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.89383","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,4]]}}}